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Abstract 
 
Background 
 
With microarray technology becoming mature and popular, the selection and use of a small 
number of relevant genes for accurate classification of samples is a hot topic in the circles of 
biostatistics and bioinformatics. However, most of the developed algorithms lack the ability to 
handle multiple classes, which arguably a common application. Here, we propose an extension 
to an existing regularization algorithm called Threshold Gradient Descent Regularization 
(TGDR) to specifically tackle multi-class classification of microarray data. When there are 
several microarray experiments addressing the same/similar objectives, one option is to use 
meta-analysis version of TGDR (Meta-TGDR), which considers the classification task as   
combination of classifiers with the same structure/model while allowing the parameters to vary 
across studies. However, the original Meta-TGDR extension did not offer a solution to the 
prediction on independent samples. Here, we propose an explicit method to estimate the 
overall coefficients of the biomarkers selected by Meta-TGDR. This extension permits broader 
applicability and allows a comparison between the predictive performance of Meta-TGDR and 
TGDR using an independent testing set. 
Results 
Using real-world applications, we demonstrated the proposed multi-TGDR framework works 
well and the number of selected genes is less than the sum of all individualized binary TGDRs. 
Additionally, Meta-TGDR and TGDR on the batch-effect adjusted pooled data approximately 
provided same results. By adding Bagging procedure in each application, the stability and 
good predictive performance are warranted. 
Conclusions 
Compared with Meta-TGDR, TGDR is less computing time intensive, and requires no samples 
of all classes in each study. On the adjusted data, it has approximate same predictive 
performance with Meta-TGDR. Thus, it is highly recommended.   
  
Keywords: Threshold Gradient Descent Regularization (TGDR); multiple classes; meta-
analysis; batch-effect adjustment; feature selection algorithm.    
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Background 
 
Biomarker discovery from high-dimensional data is a crucial problem with enormous 
applications in areas of biomedical research and translational medicine. Selecting a small 
number of relevant features (e.g., genes in transcriptomics profiles, SNPs in GWAs studies, 
and metabolites in metabolomics) to build a predictive model that can accurately classify 
samples by their diagnosis (e.g., diseased or health, different stages of one specific cancer) 
and prognosis (e.g., potential response to a given treatment, 5-year survival with a certain 
treatment) is an essential step towards personalized medicine. In bioinformatics, such a task is 
accomplished by a feature selection algorithm, which besides reducing over-fitting and 
improving classification accuracy, leads to small molecular signatures with manageable 
experimental verification and the potential design of cheap dedicated diagnostic and 
prognostic tools.  
 
Among dozens to hundreds of proposed feature selection algorithms [1-3], the Threshold 
Gradient Decent Regularization (TGDR) proposed by Friedman and Popescu [4] stands out 
because of the elegant theory beneath them; easy to moderate programming for a well-trained 
statistician; good performance and biologically meaningful results in real-world applications.  
Ma and Huang[5] elegantly extended the TGDR to the case where expression data from 
several studies are combined. The proposed algorithm, the Meta Threshold Gradient Descent 
Regularization (Meta-TGDR), assumes that the same set of genes is selected on all studies, 
while allowing the β coefficients to vary across studies, in a meta-analysis fashion. In their 
paper, they demonstrated that a better classification performance was achieved by using 
Meta-TGDR rather than by using TGDR on the combined data set.  
 
However, both originally proposed TGDR and Meta-TGDR frameworks do not give the explicit 
definition or/and format on the multi-class classification where an observation needs be 
categorized into more than two classes.  Additionally, Meta-TGDR[5] does not offer an overall 
predictive rule on an independent data set (testing samples), from a study not used in classifier 
training/estimation. The absence of such rule prevented Meta-TGDR from the evaluation of its 
performance on independent testing sets, and the comparison with TGDR in terms of 
predictive performance. Furthermore, it limited the use of the Meta-TGDR to real, clinical 
practice application precluding its use in personalized medicine, where a classifier is built for 
use in an extended population under variable laboratory setting.  
 
In this paper, we specifically addressed the first issue by proposing a new framework, referred 
as to multi-TGDR, and the second issue by proposing an equation. Lastly, the results from 
Meta-TGDR, and TGDR on the pooled data were compared in terms of their predictive 
performance.       
 
Methods and Material  
 
The proposed extensions to TGDR and meta-TGDR 
 
In order to establish the nomenclature to be used through the paper and to help the reader 
experience we start with a brief description of the Meta-TGDR as below. The interested 
readers are referred to [5] for more details on both TGDR and Meta-TGDR frameworks.  
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Let Y m = (Y1m,...,Ynmm )  be the indicator function (i.e., 0 if in the reference class, 1 otherwise) for 
each study m=1,..,M with nm subjects and Xm = (X1m,...,Xnmm )  the vector of nmxD matrices 
representing the gene expression  for each subject over the same set of D genes.  The 
likelihood function for study m can be written as:  
Rm (βm ) = Yjm × (β0m +βmX j )− log(1+ exp(β0m +βmX j ))( )j=1
nm∑ (1)  
  
where β0
m   and βm = (β1m,...,βDm )  are the unknown intercept  and expression-coefficients for 
each study s. The overall likelihood function can be written as R(β)=R1(β1)+…+RM(βM) with 
β = (β1,...,βM ) . Only the βis are subject to regularization. 
 
Denote Δv as the small positive increment (e.g., 0.01) as in ordinary gradient descent 
searching and vk=k×Δv as the index for the point along the parameter path after k steps. Let  
β(vk) denote the parameter estimate of β corresponding to vk. For a fixed threshold 0 ≤τ≤ 1, the 
Meta-TGDR algorithm can iterate on the following steps: 
 
1. Initialize β(0)=0 and v0=0.  
2. With current estimate β,  
i) Compute the negative gradient matrix gj,m (v) = −∂Rm (βm ) /∂β jm    
    ii) Define the meta-gradient G(v) as a D-dimensional vector whose jth-element is the sum 
of the gradient for each study; i.e.,
 
Gj (v) = gj,mm=1
M
∑ (v) .  
    iii) if max j{|Gj (v) |} = 0 , stop the iteration.  
3. Compute the threshold vector f(v) of length D, where the jth component of f(v): 
f j (v) = I(|Gj (v) |≥ τ ×maxl (|Gl (v) |)  
4. Update β(v+Δv)=  β(v) - Δv×g(v)×f(v) and update v by v+Δv , where the product of f and g 
is component-wise. 
5. Steps 2-4 are iterated k times. Both  τ and k are tuning parameters and determined by 
cross validation.  
 
Multi-TGDR: Extension to multi-class classification 
 
Multiple-class classification is commonly encountered in real world, however, many proposed 
feature selection algorithms lack the valuable capacity of dealing with multi-class classification. 
In the original TGDR and Meta-TGDR framework, multi-class classification had been left 
untouched even though all authors claimed that such extension is very natural. Here, we 
propose an extension of the TGDR framework to multi-class cases.  
 
In the multi-class scenario, the response variable Yi -representing the class membership for 
subject i - may take values 1,…,K, where K is the number of classes (K≥3). Propositions to 
tackle this problem using existing binary classifiers divided into two major types: “one-versus-
the rest” where K binary classifiers were trained to distinguish the samples in a single class 
from the samples in all remaining classes, and “one-versus-another” where K(K-1)/2 classifiers 
were trained to distinguish the samples in a class from the samples in one remaining class.  
Many researchers [7-9] had demonstrated that one-versus-another schema offered better 
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performance than one-versus-the rest did. Therefore, we compared our proposed framework 
with one-versus-another schema only.  
 
The central idea of our extension is to replace the single indicator variable Yi for each sample 
for a set of K-1 variables Yik. The threshold function is then defined as the maximum along the 
set of local threshold functions, defined on the subspaces defined by parameters associated to 
each class. To our knowledge, multi-class TGDR has not been addressed; probably because it 
is more computationally demanding than binary TGDR.  
 
Let Yk1,…,Ykn be the vector of indicators for class k across subjects; i.e., Ykj is equal to 1 if the 
jth subject belongs to class k and zero otherwise. This vector is defined for each class k 
(k=1,…,K-1), so the Kth-class serves as the reference class. As before, let X1,…,Xn represent 
the gene expression values. After a simple algebraic manipulation，the log-likelihood function 
can be written as:  
R(β) = Ykj ×
k=1
K−1
∑ (βk0 +βkX j )− log(1+ exp(βk0 +βkX j )
k=1
K−1
∑
$
%
&
'
(
)
j=1
n
∑ (2)  
           
 
βk0’s are unknown intercepts which would be not subject to regularization.  βk= (βk1,…, βkD) are 
the corresponding coefficients for expression values for the same set of D genes for the 
comparison between class k and reference class K. Note, the dimension of all βk  is restricted 
to be the same, but their magnitudes differ. Hence the same number of non-zero genes is 
used on all classes but their estimated values are different.  
 
Let β = βk0{ ,βk}k=1
K−1  denote the set of all parameters to be estimated in model 3, one can follow 
the binary TGDR procedure as detailed in [5, 10, 11] but introducing the following modification 
in the calculation of the threshold vector f(v) in step 3: 
 
Here, fki (v)  represents the threshold vector of size D for class k (k=1,..,K-1),  
fki (v) = I(| gki (v) |) ≥ τ ×maxl∈βk (| gkl (v) |) for i ∈ βk  
Then, the ith-gene specific element of threshold function f(v) will be obtained as:  
fi (v) =maxk fki( )  
Thus, when one gene was selected in one comparison, it would appear in the rest 
comparisons but it may not differ significantly from zeros in those comparisons.  
 
Although here we establish a unique τ tuning parameter, this assumption may be loosed so 
that τ can have different values for each class, which will allow different degree of 
regularization for different comparisons. Here, the proposed framework is referred to as multi-
TGDR.   
 
Multi-class Meta-TGDR 
  
The Multi-TDGR can naturally be extended to a situation with multiples studies and multiple 
classes. The step 3 in multi-class TGDR is combined with the concept of meta-gradient of 
Meta-TGDR. That means fki is defined on the meta-gradient instead of the regular gradient, i.e., 
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fki (v) = I(|Gki (v) |) ≥ τ ×maxl∈βk (|Gkl (v) |) for i ∈ βk and fi (v) =maxk ( fki ) . Obviously, it is more time-
consuming compared to multi-class TGDR. In this paper, this framework is referred as to Meta-
multi-TGDR.  
 
Prediction of new samples using Meta-TGDR 
 
In the Meta-TGDR, the estimated coefficients β = (β1,…,βD), corresponding to expression 
values for D genes selected, are different in each study. This raises a question of how to use 
these study-specific coefficients to perform an overall prediction in a new independent sample 
(“testing sample”), not previously used in the training/estimation stage.  However [5] did not 
offer a solution to this issue, which preclude the evaluation of the performance of the Meta-
TGDR (and its comparisons with TGDR) on independent “testing” samples. Here we extended 
their work by conducting a meta-regression to synthesize the results from Meta-TGDR and 
extrapolate the membership prediction to a sample from a new study. Under the Meta-TGDR 
settings, let Zij be the estimated log odds for the jth sample in ith study using the estimated 
coefficients βˆ i  (of length D) for each study (i.e., Zij = Xji βˆ i ). Zij can be modeled as: 
Zij = µ0 +µ1X1 j +...µDXDj +εij i =1,...,M j =1,...,ni (3)  
where µ1,…, µD represents the overall coefficient associated with gene i, εij ~ N(0,σ i2 )   and σ i2   
is the within-study variance for the study i.  Specification of equation 3 can be achieved by 
following a 3-step procedure with the first two steps obtain estimates of σ i
2 using delta 
method[6] and step 3 calculates the posterior probabilities using the estimated  coefficients 
obtained in step 2.  
 
1. ConsiderE(Yij | Xij ) = exp(Zij ) / (1+ exp(Zij )) , and E(Yi ) = E(E(Yij | Xij )) . For each study 
estimate the variance of Y in natural scale by: 
Si = (Yijj=1
nj∑ −E(Yij | Xij ))2 / ni  
2. Estimate  𝜎!! using delta-method i.e.,  
σˆ i
2 = Si / (E(Yi )× (1−E(Yi ))2  
Once we have σˆ i
2 , the overall estimated coefficients µs can be easily obtained by a 
weighted least square equation (similar to the one used in fixed-effect meta-analysis).   
3. Finally, the overall µi’s estimated in step 2 is used to calculate the odd-ratio and the 
posterior class-membership probability for a new sample. 
 
Miscellaneous 
 
Stabilization of the selected genes using Bootstrap aggregating 
 
In order to improve the stability and classification accuracy of multi-class TGDR, we applied 
Bootstrap aggregating (Bagging) to our classifier [12]. Given a training set of size n, bagging 
generates m new training sets, each of size n, by sampling subjects from the original training 
set with replacement. Then m multi-class TDGRs are conducted using the above m bootstrap 
samples and combined by voting. Bagging helps to protect over-fitting which usually exists in 
the classification setting.  
  7 
 
Evaluation of predictive performance 
 
The performance of a classifier is measured using traditional performance metrics over the 
training samples (training and cross-validation errors) and over the test samples (the predictive 
error). Since the membership probabilities for each sample can easily being obtained from 
TGDR algorithm we also used the generalized Brier score (GBS) proposed by Yeung et al [13] 
as a generalization of the Brier Score to a multi-class classification problem. Under the K class 
setting, where Yik are indicator functions of class k (k=0,1,…,K−1), let 𝑝!" denote the predicted 
probability such that Yik=1. For easier interpretation and comparison of GBS score across 
different classification settings, we normalized the GBS by the sample size n as in [14] i.e., 
(Yikk=0
K−1
∑ − pˆik )2 / 2n . By taking into consideration the magnitudes of predicted probabilities, GBS, 
can establish difference in performance of classifiers with same overall predictive error. The 
smaller the GBS value, which after normalization takes values in [0,1], the better a classifier 
performs.  
 
The Experimental Data and preprocessing procedures  
 
Psoriasis: Open-access data from 3 published studies [15-17] available under GEO accession 
numbers GSE14905, GSE13355, and GSE30999, respectively were used, including samples 
from Lesions (LS) and adjacent Non-Lesional (NL) skin form psoriasis patients and Normal 
skin from healthy patients. Details of these studies - using Hgu133plus2 Affymetrix chips- are 
given in [18].  
 
Lung cancer: The lung cancer data sets included GSE10245, GSE18842, and GSE2109, all 
studies were performed on Affy HGU 133plus2 chips and publicly available on the GEO 
repository.  
 
Pre-processing procedures: The raw Affymetrix data (CEL files) of both lung cancer and 
psoriasis data sets were downloaded from GEO repository and expression values were 
obtained using FRMA algorithm [19]. To pool data from different studies together and to 
address the batch effects from different experiments, COMBAT algorithm [20] was used to 
adjust on the combined expression values for these two combined data sets. For the lung 
cancer data, moderated F/t-tests (limma package) were conducted to identify differentially 
expressed genes (DEGs) with cutoffs for FDR and fold change as 0.05 and 2, respectively. 
When there are multiple probesets representing the same gene, the one with the largest F-
value was chosen. The resulting 949 unique genes were fed into the downstream analysis. 
Note, for the TGDR algorithm there is no limit on the number of genes fed into the algorithm. 
However, we usually used a filtering procedure to rule out the non-informative genes before 
the classification. By doing so, a large amount of computing time can be saved with only partial 
set of genes put in classifiers; but with no or least loss on the potential biomarkers since 
almost all genes which have high probability to be biomarkers pass the filtering. For psoriasis 
data, the filtering steps taken (including SD, ICC and DEGs using meta-analysis method) were 
used by us previously and described in details there [18]. Similar to the lung cancer data, 
conducting those filtering steps is mainly for the purpose of saving the computing time. 2301 
unique genes passed the filtering were fed into multi-TGDR and Meta-TGDR algorithms.  
 
Statistical language and packages 
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The statistical analysis was carried out in the R language version 2.15 (www.r-project.org), and 
packages were from the Bioconductor project (www.bioconductor.org). R code for multi-TGDR 
is available upon request.  
 
Results and Conclusions 
 
Simulation studies 
 
In this section, we use two simulated examples to study the empirical performance of multi-
TGDR.  
 
Example 1  
 
In the first simulation, 100×n iid standard normal (mean=0, variance=1) random variables (i.e., 
X1,…,X100, those are vectors of length n, n is the sample size), and n class membership 
outcome variables (Y1,…,Yn) taking the values of 1-3 were simulated. The logit function for 
class 2 and 3, having class 1 as reference, was calculated through the following relationship: 
 
f1 = 0.5− 2X1 +1.2X2 + 0.8X3
f2 = −1.5+1.7X1 −1.5X2 − X4
 
 
where the logit for class 2 depends only on features X1 X2 X3 and class 3 logit depends on 
features 1,2 and 4. According to this model, 50 data sets were generated and analyzed by the 
proposed multi-TGDR framework. Results for this simulation, summarized in Table 1A shows 
that almost 100% of times the relevant features were selected by multi-TGDR framework. As 
criticized by Wang et al [21], lack of parsimony is an obvious disadvantage of TGDR 
algorithms, a shortcoming inherited by the multi-TGDR. However, the introduction of the 
Bagging procedure improves upon parsimony.  
  
Example 2 
 
To explore the effect of the correlations among features (i.e., independent variables) may have 
on multi-TGDR, we set the simulations as in the previous example but assumed the following 
correlations among features: cor(X1, X5) =cor(X3, X7)=0.8 and cor(X2, X6) =cor(X4, X8)=-0.8. 
Table 1B presents the results for this simulation. When compared with the uncorrelated 
scenario of example 1, the size of final selected feature is marginally larger while the predictive 
errors are almost the same. Nevertheless, multi-TGDR always selected the relevant features 
successfully and has good predictive performance. Bagging procedure improves upon both 
parsimony and predictive performance. Thus, it is highly recommended to combine bagging 
with any TGDR algorithm although bagging is very computing-time intensive.   
 
Applications on microarray expression data  
 
Using the real-world applications, the appropriateness and accuracy of the proposed multi-
TGDR was evaluated.  We also compared the performance of Meta-TGDR and TGDR under a 
priori batch-adjustment.  
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Lung cancer 
 
About 80% of lung cancers (LC), the leading cause of cancer-related death throughout the 
world, are classified as non-small cell lung carcinoma (NSCLC) with Adenocarcinoma (AC) 
and squamous cell carcinoma (SCC) the two major subtypes of NSCLC. SCC is characterized 
as a poorly differentiated tumor subtype that develops in the proximal airways and is strongly 
associated with cigarette smoking. In contrast, AC usually arises in the peripheral airways and 
is more commonly observed in non-smokers and women. Mutations have been identified in AC 
and not in SCC, suggestion different mechanism of progression and treatment response. 
 
For LC data, we randomly divided it into 4 subsets with roughly equal sizes and used 3 fold of 
them as the training set (n=109) and the remained 1-fold as the test set (n=36). Using multi- 
TGDR algorithm, 67 biomarkers were identified with 0% training error and a predictive error of 
20.2% in a 5-fold cross-validation (CV). The comparison between pair-wise TGDRs and the 
multi-class TGDR is summarized in Table 2, and it shows that multi-TGDR over-perform the 
pair-wise strategy in all performance statistics.  
 
After applying Bagging (NB=100) to the LC data, we found that all genes in the 67-gene 
signature produced by multi-TGDR appear in the classifier with more than 5% frequency and 
19 of them has bragging frequencies (BF) larger than 40% (Table 3). CYP24A1 is the gene 
most frequently selected (77%) followed by PNLDC1 (67%). By reducing the multi-TDGR 
signature to those genes with BF>40%, the performance showed slightly improvement by a 
predictive error reduction of 2.78% on the test set.  
 
We concluded that bagging procedure discarded the random noises produced by a single run 
of TGDR. Furthermore, the calculation of membership probabilities in multi-class TGDR is 
more straightforward compared to the pair-wise coupling. Given it is intrinsically challenging to 
derive meaningful diagnostic signatures from high-throughput experiments in complicated 
problems like this, one major objective of presenting this data set is to use it as a benchmark 
for the development of more suitable classifiers on lung cancer subtypes and stages.  
 
Psoriasis 
 
Psoriasis vulgaris is a common chronic inflammatory skin disease of varying severity, 
characterized by red scaly plaques. Publicly data from 3 published studies [15-17] were used, 
including samples from Lesional (LS) and adjacent Non-Lesional (NL) skin of psoriasis patients 
and Normal skin from healthy patients.  
 
Here, we used the psoriasis data to investigate the effect of the Batch/study adjustment in the 
performance of TGDR and Meta-TGDR, as well as to further evaluate multi-TGDR. Again, we 
randomly divided the whole data into 5 subsets with roughly equal sizes and used 4 fold of 
them as the training set (n=360) and the left one fold as one test set (n=89). By doing so, we 
can evaluate the validity of the proposed equation for the overall estimates since both the 
study-specific and overall estimates are available for the samples in this test set.  
 
Here, we first present the performance of the binary classifiers followed by the multi-class 
problem. The binary classifiers (LS vs Normal, LS vs NL and NL vs Normal) will allow us 1) to 
assess the effect of batch adjustment on the performance of TGDR and Meta-TGDR and 2) to 
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evaluate the validity of the method proposed here to allow prediction of independent data set in 
the Meta-TDGR framework.  
 
Binary Classification Problems in Psoriasis Data 
 
The results for all 3 comparisons were presented in Table 4A. The positive effect of batch 
adjustment on Meta-TDGR’s performance is striking and consistent across all comparisons 
and datasets. When the data were adjusted for batch effect before classification, TGDR and 
Meta-TGDR had identical miss-classification rates on training and testing samples in all 3 
comparisons and TGDR slightly outperformed in terms of GBS.  
 
LS versus normal: Using TGDR on batch-adjusted expression from LS and Normal skin 
samples, we identified 30 biomarkers with a 0% and 0.86% training and CV-5 error, 
respectively. Bragging (NB=100) frequencies were above 5% for all 30 genes. By considering a 
series of cutoff values for the frequency (5%-50%), a 30% for BF was chosen as it minimized 
the GBS and misclassification rates with the smallest number of non-zero genes leading to a 
final model with 18 genes (Table 4). Meta-TGDR (after batch adjustment) identified 22 
biomarkers all with BF>5%. Cut-off for BF was set at 40% and among the 10 selected genes 
(see Table 5), 6 (p<0.0001) overlapped with the 18 genes in the TGDR bagging classifier.   
 
LS versus NL: TGDR signature for LS vs NL classification included 35 biomarkers with a 
training error of 0% and 1.48% in 5-CV. Applying Bagging procedure (NB=100) the final model 
(with BF>30%) included 22 genes (see Table 6). Meta-TGDR on the adjusted data identified a 
25 genes signature, all with BF>5% and 16 of them above the selected cut-off of 40% for BF 
(See Table 6). There is still an impressive overlapping (n=11) between these 16 genes and the 
22 genes chosen by TGDR bagging model (Fisher’s test: p<0.0001).  
 
Although Meta-TGDR is more parsimonious, k (the number of steps) is always dramatically 
bigger than in TGDR for the same value of the tuning parameter τ in both algorithms. One 
possible explanation is that by allowing different coefficients for a specific gene across studies, 
the direction of updating path in individual study may differ, probably leading to a cancel-out 
among one another. Therefore, the gradients might descend at higher speed in TGDR than 
meta-gradients in Meta-TGDR and the maximized likelihood value might be reached within 
fewer steps.  
 
Psoriasis 3-class classification 
 
Here we evaluate the performance of the multi-TGDR versus the classifier build using all 
pairwise binary TGDRs. The performance of the Meta-multi-TGDR for adjusted and unadjusted 
data is also presented. 
 
Using multi-TGDR on the training set, we identified 60 genes with 0% training error 1.67% 
error in 5 fold CV. Interestingly, the number of selected genes by multi-TGDR is approximately 
the sum of all individualized binary TGDRs: with 39 genes (Table 6) having bagging frequency 
larger than the selected cut-off (40%). Again, disposal of the low-BF genes did not hurt the 
predictive performance. On the contrary, it improves the predictive performance in terms of 
GBS for both training and testing samples.  
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The classifier built by combining the 3 pairwise binary TGDR had the same in-training 
performance as multi-TGDR using 76 genes, with 44 of them being part of the multi-TGDR 
classifier (p<0.0001). The inconsistency between two algorithms is partially because local 
optimal points in individualized binary TGDRs cannot warrant the global optimality in the multi-
TGDR.  With this data set, multi-TGDR and pairwise binary TGDR had similar performance 
while multi-TGDR was more parsimonious. Multi-TGDR with Bagging provided the best 
performance (see Table 7 and Figure 1). This shed some evidence on appropriation and 
accuracy of the multi-TGDR framework. Certainly, further evaluation using independent test 
sets is needed.   
 
Surprisingly, the performance of Meta-multi-TGDR, where coefficients for both classes and 
studies are included is not impressive. This may partially due to the fact that Meta-multi-TGDR 
intends to find consistent-expressed genes across all classes and studies (one possible 
reason why the number of non-zero genes in multi-Meta-TGDR is the smallest).  Based on the 
analyses conducted here, we illustrated that TGDR on the adjusted data has a similar or better 
performance compared to Meta-TGDR, thus we think Meta-multi-TGDR, with its increase 
complexity and computing burden, is quite unnecessary. Nonetheless, the Meta-multi-TGDR 
greatly improved after batch adjustment reducing training error from 18.33 to 7.11 and 
predictive error (on test set 1) from 27% to 6.74, demonstrating that the adjustment of batch 
effect is imperative.  
  
Discussion 
 
When several microarray studies address the same or similar objectives, it is statistically more 
robust to carry out the analysis by pooling all studies together. To identify molecular signatures 
that discriminate among different disease status or stages on the pooled data, one can either 
apply TGDR to the batch-effect adjusted expression values for all samples, or use Meta-TGDR 
to select consistently informative genes and obtain the overall estimates using the procedure 
we proposed in the paper. 
Using real-world applications, we showed that TGDR and Meta-TGDR have approximately 
equal predictive performance when the data has been adjusted for batch-effect. Compared to 
the latter method, TGDR on the adjusted data saves computing time, and do not require that 
all classes must be represented in each study. However, the stability of Meta-TGDR is usually 
better than TGDR as shown by the analyses of psoriasis data, and future work must be done 
to improve more on stability of TGDR. Nonetheless, applying Meta-TGDR on the unadjusted 
data had worse predictive performance compared to the analyses on the adjusted data. This 
verified our conjecture that Meta-TGDR aims mainly at selecting consistent genes across 
studies, with few to no capacity to adjust for a large batch-effect.  
 
Additionally, we assembled our analyses with the Bagging procedure [12]. The benefits of 
Bagging including improved selection stability; more classification accuracy; and protection 
against over-fitting are clearly illustrated here.  
 
In this paper, we did not compare the multi-TGDR with other classification methods. Since it is 
an extension to binary TGDR, whose performance had been proved to be equal or superior to 
many other classification methods in the original papers [10], we focus on important issues 
addressed here: comparing TGDR and Meta-TGDR performance after batch adjustment, 
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making Meta-TGDR useful in practice by offering a solution to the prediction of independent 
datasets. Because the numbers of classes in our two applications are not big (4 in LC and 3 in 
psoriasis data, respectively), future work will include some applications of the multi-TGDR 
framework with a large number of classes, where the performance of pair-coupling has been 
reported to decrease dramatically, to see if a single likelihood-based classifier like multi-TGDR 
can be a rescue.  
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Figures 
 
Figure 1. The estimated coefficients of the genes selected by multi-TGDR in the psoriasis data.  
Normal skin tissues from controls served as the reference.  NL: Non-Lesional skin; LS: Lesional skin.  
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Tables 
Table 1. The results for simulated data  
A. Simulation 1 
 % of β1≠0 
Average 
BF (%) 
% of β2≠0 
BF(%) 
% of β3≠0 
BF(%) 
% of β4≠0 
BF(%) 
Average # of 
selected 
genes  
Average 
predictive 
error (%) 
Multi-TGDR 
without bagging   
100 
100 
100 
99.98 
100 
91.48 
98 
90.64 
28.2  13.90  
Multi-TGDR 
BF>40% 
--- --- --- --- 21 13.98 
BF>80%  --- --- --- --- 5.42 11.96 
B. Simulation 2 
Multi-TGDR 
without bagging   
100 
100 
100 
100 
96 
90.88 
100 
95.48  
30.20 13.26 
Multi-TGDR 
BF>40% 
--- --- --- --- 22.62 13.20 
BF>80%  --- --- --- --- 5.54 11.08 
 
Table 2. Performance of classifiers for Lung Cancer data. 
  Training (N=109) Test set  (n=36)  
  # 
genes  
Error 
(%) 
CV 
(%) 
Predictive 
Error (%) 
GBS 
Pair-wise ACI vs ACII  13 12.77 29.78   
 ACI vs SCC I  28  0  11.63   
 ACI vs SCC II  19  0 12.00   
 ACII vs SCCI  15 0 3.39    
 ACII vs SCCII  13 0 8.70   
 SCCI vs SCC II  44 22.58 35.48   
 Overall 107 18.34  51.38  50.00 0.302 
Multi-TDGR No Bagging  67 0 20.2% 47.22 0.292 
 with Bagging 19 9.17 --- 44.44 0.303 
 
Table 3. Multi-TGDR genes for lung cancer data after Bagging. Here, AC-I serves as the reference. Bagging 
frequency>40%. 
Probe Symbol Description βAC-II βSCC-I βSCC-2 Freq 
206504_at CYP24A1 cytochrome P450, family 24, subfamily A, polypeptide 1 0.2931 -0.3501 0.0692 0.77 
1564414_a_
at PNLDC1 
poly(A)-specific ribonuclease (PARN)-like domain 
containing 1 -0.0499 -0.0942 0.3569 0.67 
211416_x_at GGTLC1 gamma-glutamyltransferase light chain 1 -0.2747 -0.1519 -0.1726 0.65 
206059_at ZNF91 zinc finger protein 91 -0.0755 0.0557 -0.2927 0.55 
205348_s_at DYNC1I1 dynein, cytoplasmic 1, intermediate chain 1 0.1083 0.0092 0.388 0.54 
231867_at ODZ2 odz, odd Oz/ten-m homolog 2 (Drosophila) 0.0065 0.2616 -0.0077 0.51 
219926_at POPDC3 popeye domain containing 3 0.4104 0.1598 0.1239 0.51 
219298_at ECHDC3 enoyl CoA hydratase domain containing 3 -0.0718 0.0835 -0.3062 0.5 
203358_s_at EZH2 enhancer of zeste homolog 2 (Drosophila) -0.5307 -0.0307 0.4366 0.49 
214464_at CDC42BPA CDC42 binding protein kinase alpha (DMPK-like) -0.0406 -0.3358 -0.1537 0.48 
210020_x_at CALML3 calmodulin-like 3 -0.0172 0.2187 0.0875 0.46 
201839_s_at EPCAM epithelial cell adhesion molecule -0.0045 -0.0408 -0.0017 0.45 
238983_at NSUN7 NOP2/Sun domain family, member 7 0.0135 -0.2718 -0.019 0.45 
206677_at KRT31 keratin 31 0.0076 -0.0138 0.1216 0.44 
235706_at CPM carboxypeptidase M 0.1549 -0.0625 0.0164 0.43 
226213_at ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) -0.0138 -0.1827 -0.0757 0.43 
205713_s_at COMP cartilage oligomeric matrix protein 0.0632 -0.2135 0.048 0.41 
228846_at MXD1 MAX dimerization protein 1 0.026 0.0184 0.0838 0.41 
227492_at OCLN Occluding 0.0015 -0.4148 -0.1417 0.41 
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Table 4. Performance of Classifiers for Psoriasis data. A. Comparison between TGDR and Meta-TGDR for 
binary classifiers. B. Comparisons between TGDR and Meta-TGDR for 3-class classifiers.  
A.                                                        Binary Classifiers 
  Training (n=360)  Test set  (n=89) 
 Method #  genes 
Error 
(%) 
5-fold 
CV (%) GBS 
PE 
(%) GBS 
LS vs Normal 
 
 
Training: 233 
Test:    49 
 
TDGR (adjusted) 30 0 0.86 0.0001 0 0.0006 
Meta-TGDR (unadjusted) 18 0 0.86 0.0010 2.04 0.0084 
Meta-TGDR (adjusted) 22 0 0.86 0.0006 0 0.0028 
TDGR w/Bagging  
(adjusted, BF>30%) 18 0 --- 0.0011 0 0.0004 
Meta-TGDR w/Bagging 
(adjusted, BF>30%) 10 0 --- 0.0012 0 0.0032 
LS vs NL 
 
 
Training: 271 
Test: 68 
TDGR (adjusted) 35 0 1.48 0.0009 1.47 0.0136 
Meta-TGDR (unadjusted) 26 1.11 1.85  0.0105 2.94 0.0294 
Meta-TGDR (adjusted) 25 0 1.48 0.0036 1.47 0.0143 
TDGR w/Bagging 
(adjusted, BF>30%) 22 0 --- 0.0021 1.47 0.0144 
Meta-TGDR w/Bagging 
(adjusted, BF>40%)  16 1.48 --- 0.0041 1.47 0.0142 
NL vs Normal 
 
 
Training: 216 
Test:  61  
TDGR (adjusted) 26 0 0 1.5 x10-5 0 7.3x10-5 
Meta-TGDR (unadjusted)  40 5.56 18.06 0.0570 8.20 0.0659 
Meta-TGDR (adjusted) 22 0 1.85 0.0032 0 0.0054 
TDGR w/Bagging 
(adjusted, BF>30%) 24 0 --- 2.4x10
-5 0 7.3x10-5 
Meta-TGDR w/Bagging 
(adjusted, BF>40%) 21 0 --- 0.0033 0 0.0054 
B.                                                        Multiclass Classifiers 
Method  #  genes 
Error 
(%) 
5-fold 
CV (%) GBS 
PE 
(%) GBS 
Pairwise-coupling  76 0 1.67 0.0067 0 0.0013 
Multi-TDGR Adjusted  60 0 1.67 0.0144 0 0.0013 
 Bagging (BF>40%)  39 0 --- 0.0052 0 0.0006 
Multi-Meta-TGDR Unadjusted  5 18.33 21.39 0.1734 26.97 0.1629 
 Adjusted  13 7.77 8.61 0.1296 6.74 0.0393 
 
Table 5 Psoriasis LS versus Normal genes by TGDR and Meta-TGDR after Bagging. Here, Normal skin 
samples serve as the reference. Bagging frequency>30% for TGDR and >40% for Meta-TGDR. 
 TGDR Meta-TGDR 
Probe Symbol Description β βYao βGud βSF+ β 
229963_at BEX5 brain expressed, X-linked 5 -0.2958     
207356_at DEFB4A defensin, beta 4A 1.9258 1.3188 2.1196 1.6617 1.9405 
224209_s_at GDA guanine deaminase 0.8995 1.3512 1.4587 1.1601 1.5021 
202411_at IFI27 interferon, alpha-inducible protein 27 0.69 0.0313 0.083 0.0556 0.2784 
1555745_a_at LYZ lysozyme 0.312 0.1929 0.0934 0.1837 0.0633 
205916_at S100A7 S100 calcium binding protein A7 0.6612 0.2597 0.414 0.2862 0.4206 
212492_s_at KDM4B lysine (K)-specific demethylase 4B -0.1272     
201846_s_at RYBP RING1 and YY1 binding protein -1.4184 -0.3202 -0.1995 -0.4103 -0.2907 
201416_at SOX4 SRY (sex determining region Y)-box 4 -0.1703     
215363_x_at FOLH1 
folate hydrolase (prostate-specific membrane 
antigen) 1 0.3342     
203335_at PHYH phytanoyl-CoA 2-hydroxylase -0.3569     
205758_at CD8A CD8a molecule 0.1235     
1556069_s_at HIF3A hypoxia inducible factor 3, alpha subunit 0.2577     
213424_at KIAA0895 KIAA0895 -0.3158     
205132_at ACTC1 actin, alpha, cardiac muscle 1 -0.1815     
1431_at CYP2E1 
cytochrome P450, family 2, subfamily E, polypeptide 
1 0.2671     
230005_at SVIP small VCP/p97-interacting protein -0.1723     
202668_at EFNB2 ephrin-B2 -0.1202     
  17 
205471_s_at DACH1 dachshund homolog 1 (Drosophila)  -0.1171 -0.0807 -0.0722 -0.0721 
229625_at GBP5 guanylate binding protein 5  0.1256 0.0786 0.0659 0.1468 
213293_s_at TRIM22 tripartite motif containing 22  0.1796 0.1428 0.1477 0.0042 
202267_at LAMC2 laminin, gamma 2  -0.0785 -0.0844 -0.0971 -0.0942 
 
Table 6. Psoriasis LS versus NL genes by TGDR and Meta-TGDR after Bagging. Non-lesional skin samples 
serve as the reference. Bagging frequency>30% for TGDR and >40% for Meta-TGDR. 
 TGDR Meta-TGDR 
Probe Symbol Description β βYao βGud βSF+ β  
210002_at GATA6 GATA binding protein 6 -0.1895     
235603_at HNRNPU 
heterogeneous nuclear ribonucleoprotein U (scaffold 
attachment factor A) -0.7306 -0.4787 -0.4382 -0.5031 -0.694 
231875_at KIF21A kinesin family member 21A -0.1396     
233819_s_at LTN1 listerin E3 ubiquitin protein ligase 1 -0.0771     
203476_at TPBG trophoblast glycoprotein 0.4798 0.1412 0.2202 0.2286 0.5236 
234335_s_at FAM84A family with sequence similarity 84, member A -0.1498     
230828_at GRAMD2 GRAM domain containing 2 -0.4782 -0.0935 -0.1705 -0.306 -0.1539 
224171_at LSM14B LSM14B, SCD6 homolog B (S. cerevisiae) -0.2053     
230699_at PGLS 6-phosphogluconolactonase -0.5561 -0.0144 -0.2076 -0.328 -0.1485 
1552797_s_at PROM2 prominin 2 -0.1398     
226404_at RBM39 RNA binding motif protein 39 -0.0434 -0.1364 -0.155 -0.1385 -0.2417 
202648_at RPS19 ribosomal protein S19 -0.4381 -0.3294 -0.6499 -0.9706 -0.7572 
230586_s_at ZNF703 zinc finger protein 703 -0.76 -0.1284 -0.3829 -0.2787 -0.9174 
211661_x_at PTAFR platelet-activating factor receptor 0.7216     
203335_at PHYH phytanoyl-CoA 2-hydroxylase -0.3971     
213849_s_at PPP2R2B protein phosphatase 2, regulatory subunit B, beta -0.1023     
226367_at KDM5A lysine (K)-specific demethylase 5A -0.3457 -0.0369 -0.0484 -0.0447 -0.0001 
228132_at ABLIM2 actin binding LIM protein family, member 2 -0.5047 -0.5503 -0.5072 -0.5825 -0.7550 
202267_at LAMC2 laminin, gamma 2 -0.1007 -0.0953 -0.0976 -0.1271 -0.0387 
213424_at KIAA0895 KIAA0895 -0.2031     
205132_at ACTC1 actin, alpha, cardiac muscle 1 -0.2045     
203127_s_at SPTLC2 serine palmitoyltransferase, long chain base subunit 2 1.3511 0.4363 0.665 0.7786 0.9813 
201487_at CTSC cathepsin C  0.0171 0.0155 0.0174 0.0000 
217388_s_at KYNU Kynureninase  0.1287 0.1755 0.1958 0.0002 
205863_at S100A12 S100 calcium binding protein A12  0.3597 0.5641 0.5861 0.0486 
243417_at ZADH2 zinc binding alcohol dehydrogenase domain containing 2  -0.1611 -0.1703 -0.1686 -0.1063 
211661_x_at PTAFR platelet-activating factor receptor  0.6241 0.6422 0.7737 0.9329 
 
Table 7. Psoriasis 3 classes genes selected by multi-TGDR after Bagging. There are 39 genes in the final 
model. Normal tissue from healthy controls serves as the reference. Bagging frequency>40%. 
Probe Symbol Description β_NL β_LS Freq 
203872_at ACTA1 actin, alpha 1, skeletal muscle 0.1043 -0.2438 0.51 
229963_at BEX5 brain expressed, X-linked 5 -0.0688 -0.8066 0.75 
207356_at DEFB4A defensin, beta 4A 0.3202 0.672 0.46 
235603_at HNRNPU 
heterogeneous nuclear ribonucleoprotein U (scaffold 
attachment factor A) 0.2325 -0.4157 0.68 
205863_at S100A12 S100 calcium binding protein A12 -0.9565 1.6449 0.42 
205916_at S100A7 S100 calcium binding protein A7 0.4054 0.9465 0.81 
226825_s_at TMEM165 transmembrane protein 165 -0.0338 0.0811 0.58 
206373_at ZIC1 Zic family member 1 0.2361 0.0792 0.59 
203239_s_at CNOT3 CCR4-NOT transcription complex, subunit 3 -0.2049 -0.3561 0.43 
201693_s_at EGR1 early growth response 1 -0.182 -0.094 0.47 
234335_s_at FAM84A family with sequence similarity 84, member A 0.542 -0.0105 0.99 
214711_at GATC 
glutamyl-tRNA(Gln) amidotransferase, subunit C homolog 
(bacterial) -0.1048 0.0458 0.45 
230828_at GRAMD2 GRAM domain containing 2 0.4728 -0.0949 0.85 
207764_s_at HIPK3 homeodomain interacting protein kinase 3 0.032 -0.3303 0.54 
212492_s_at KDM4B lysine (K)-specific demethylase 4B -0.6416 -0.4202 0.88 
214352_s_at KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog -0.1416 -0.0083 0.55 
224171_at LSM14B LSM14B, SCD6 homolog B (S. cerevisiae) 0.443 0.0658 0.93 
1556175_at MTSS1L metastasis suppressor 1-like 0.3438 0.015 0.85 
  18 
202600_s_at NRIP1 nuclear receptor interacting protein 1 -0.1361 -0.3617 0.61 
230699_at PGLS 6-phosphogluconolactonase 0.4517 -0.049 0.79 
229392_s_at PIK3R2 phosphoinositide-3-kinase, regulatory subunit 2 (beta) 0.6238 -0.101 0.78 
1552797_s_at PROM2 prominin 2 0.5688 0.0752 0.84 
229806_at QRICH1 glutamine-rich 1 1.2418 -0.6387 0.86 
226404_at RBM39 RNA binding motif protein 39 0.4885 -0.0797 0.96 
202648_at RPS19 ribosomal protein S19 0.2297 -0.0548 0.9 
201846_s_at RYBP RING1 and YY1 binding protein -1.4064 -1.2206 0.99 
1563646_a_at TMEM67 transmembrane protein 67 0.2242 0.0222 0.48 
243417_at ZADH2 zinc binding alcohol dehydrogenase domain containing 2 0.5824 -0.0841 0.92 
230586_s_at ZNF703 zinc finger protein 703 1.3228 -0.0688 0.99 
215363_x_at FOLH1 folate hydrolase (prostate-specific membrane antigen) 1 0.2521 0.5247 0.71 
211661_x_at PTAFR platelet-activating factor receptor -0.1189 0.1913 0.51 
203335_at PHYH phytanoyl-CoA 2-hydroxylase 0.4112 -0.9118 0.61 
202275_at G6PD glucose-6-phosphate dehydrogenase 0.0251 -0.2045 0.52 
1556069_s_at HIF3A hypoxia inducible factor 3, alpha subunit -0.0016 0.6154 0.62 
213424_at KIAA0895 KIAA0895 0.0646 -0.1698 0.48 
215695_s_at GYG2 glycogenin 2 0.0756 -0.0037 0.55 
205132_at ACTC1 actin, alpha, cardiac muscle 1 0.1735 -0.2476 0.6 
1431_at CYP2E1 cytochrome P450, family 2, subfamily E, polypeptide 1 0.0139 0.0433 0.45 
230005_at SVIP small VCP/p97-interacting protein -0.0019 -0.1661 0.43 
 
